DENTSPLY SIRONA (NASDAQ:XRAY) Stock Rating Lowered by Bank of America

DENTSPLY SIRONA (NASDAQ:XRAYGet Rating) was downgraded by analysts at Bank of America from a “buy” rating to a “neutral” rating in a research note issued to investors on Tuesday, Briefing.com reports. They presently have a $49.00 price target on the medical instruments supplier’s stock, down from their prior price target of $66.00. Bank of America‘s price target points to a potential upside of 15.38% from the company’s current price.

A number of other research analysts have also recently commented on XRAY. Barrington Research cut their price target on shares of DENTSPLY SIRONA from $79.00 to $72.00 in a report on Tuesday, March 1st. Credit Suisse Group dropped their target price on shares of DENTSPLY SIRONA from $68.00 to $67.00 and set an “outperform” rating on the stock in a report on Tuesday, March 1st. TheStreet cut shares of DENTSPLY SIRONA from a “b-” rating to a “c+” rating in a report on Friday, March 18th. Robert W. Baird cut shares of DENTSPLY SIRONA from an “outperform” rating to a “neutral” rating and dropped their target price for the stock from $67.00 to $48.00 in a report on Tuesday. Finally, William Blair cut shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Tuesday. Five analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $62.00.

Shares of XRAY traded down $6.25 during midday trading on Tuesday, hitting $42.47. The stock had a trading volume of 247,014 shares, compared to its average volume of 1,960,141. DENTSPLY SIRONA has a 1 year low of $47.06 and a 1 year high of $69.54. The firm has a market cap of $9.15 billion, a PE ratio of 22.06, a price-to-earnings-growth ratio of 1.57 and a beta of 0.86. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.55 and a quick ratio of 1.12. The stock’s 50 day moving average is $51.19 and its 200 day moving average is $53.42.

DENTSPLY SIRONA (NASDAQ:XRAYGet Rating) last announced its earnings results on Monday, February 28th. The medical instruments supplier reported $0.76 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.79 by ($0.03). DENTSPLY SIRONA had a net margin of 9.90% and a return on equity of 12.51%. The firm had revenue of $1.09 billion during the quarter, compared to analysts’ expectations of $1.13 billion. During the same period in the prior year, the company posted $0.87 EPS. The company’s revenue was up .6% compared to the same quarter last year. As a group, equities research analysts expect that DENTSPLY SIRONA will post 3.1 earnings per share for the current fiscal year.

A number of institutional investors and hedge funds have recently bought and sold shares of XRAY. NuWave Investment Management LLC raised its position in DENTSPLY SIRONA by 172.8% during the 4th quarter. NuWave Investment Management LLC now owns 502 shares of the medical instruments supplier’s stock worth $28,000 after buying an additional 318 shares during the last quarter. SOA Wealth Advisors LLC. increased its holdings in shares of DENTSPLY SIRONA by 26,666.7% during the 1st quarter. SOA Wealth Advisors LLC. now owns 803 shares of the medical instruments supplier’s stock valued at $39,000 after purchasing an additional 800 shares in the last quarter. Dark Forest Capital Management LP purchased a new position in shares of DENTSPLY SIRONA during the 3rd quarter valued at approximately $50,000. National Bank of Canada FI purchased a new position in shares of DENTSPLY SIRONA during the 4th quarter valued at approximately $55,000. Finally, Dixon Hughes Goodman Wealth Advisors LLC purchased a new position in shares of DENTSPLY SIRONA during the 1st quarter valued at approximately $79,000. 97.32% of the stock is owned by institutional investors.

DENTSPLY SIRONA Company Profile (Get Rating)

DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces.

Featured Articles

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.